Feedback / Questions
TB-Bs1 - Traverse Biotech, Genmab
https://www.prnewswire.com/news-releases/traverse-biotech-to-present-data-on-ror2-targeted-t-cell-engager-at-the-society-for-immunotherapy-of-cancers-sitc-39th-annual-meeting-302286375.html
Oct 25, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next